Lupus anticoagulants and antiphospholipid antibodies monitoring in systemic lupus erythematosus.
Ariano
C C
CC
Istituto Neurologico C. Besta, Milano, Italia.
Salmaggi
A
A
Croci
D
D
Lamperti
E
E
Bottero
P
P
Castiglione
A
A
Venegoni
E
E
La Mantia
L
L
Eoli
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D017153:Antibodies, Anticardiolipin / Q000097:blood; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D000962:Antimalarials / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000097:blood*; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D013927:Thrombosis / Q000150:complications
D017153:Antibodies, Anticardiolipin; D017152:Antibodies, Antiphospholipid; D000962:Antimalarials; D016682:Lupus Coagulation Inhibitor; D011241:Prednisone